Effect of Ca <sup>2+</sup> on GP IIb-IIIa Interactions With Integrilin
David R. Phillips(Lingnan University), Robert M. Scarborough(Scripps Research Institute), Lisa Nannizzi‐Alaimo(Scripps Research Institute), Sanford J. Shattil(University of California San Diego), Ann Arfsten(Scripps Research Institute), Joseph A. Jakubowski(Indiana Biosciences Research Institute), Melanie McCabe White(Scripps Research Institute), Lisa K. Jennings(Saint Luke's Health System), Anne Randolph(Itron (United States)), Celia M. Longhurst(University of Tennessee Health Science Center)
Cited by 248
Related Papers
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
|Circulation|2007|882
Integrin Signaling: The Platelet Paradigm
|Blood|1998|670
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
|New England Journal of Medicine|2013|651
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
|Journal of the American College of Cardiology|2012|617